Results from the study showed that the cell-free DNA blood-based test had a sensitivity of 83.1% for CRC and a specificity of ...

This group was more 46% more likely than non-late eaters to have an adenoma – a small noncancerous lesion – found during colonoscopy. An adenoma is not cancer, but an estimated 5% to 10% of them ...

CPAs are the result of gene mutations leading to the development of two-layer nodules that have tumor-inducing and ...

The U.S. FDA’s May 23 advisory hearing for the Shield test for colorectal cancer by Guardant Health Inc., included the ...

Tragic cases like Chadwick Boseman and Melissa Inouye’s are a call to action, to take young patients’ gastrointestinal ...

The PressureSafe device reduced the incidence of pressure injuries by 50% by detecting these pressure injuries to the skin ...

Guardant Health’s blood test designed to help screen the population for hidden cases of colorectal cancer may have taken a ...

WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and ...

Nasdaq temporarily halted the trading of Guardant Health (NASDAQ:GH) shares on Thursday as an FDA Advisory Committee is ...

While protruding lesions are easily diagnosed, diagnosis is more difficult for nonprotruding lesions. However, application of modern endoscopic techniques allows detection of nonprotruding neoplasia.

My male White Husky is almost 14. About two weeks ago, I noticed that he started reaching for his rear end a lot and seemed ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on GH stock, giving a Buy rating on May 22. Puneet Souda’s ...